Læknablaðið

Ukioqatigiit

Læknablaðið - 15.10.1999, Qupperneq 33

Læknablaðið - 15.10.1999, Qupperneq 33
LÆKNABLAÐIÐ 1999; 85 797 Eftirlit og meðferð kransæðasjúklinga á heilsugæslustöð Emil L. Sigurðsson' 2, Jón Steinar Jónsson3, Guðmundur Þorgeirsson4 Medical surveilance and secondarv prevention of coronary heart disease in general practice Sigurðsson EL, Jónsson JS, Þorgeirsson G Læknablaðið 1999; 85: 797-804 Objective: Prevention, both printary and secondary, is an important part in the daily work of most doc- tors. Family physicians (FP) carry the responsibility of implementing both stages of prevention. Coronary heart disease (CHD) is an example of chronic disease where FP have a responsibility both in treatment and prevention. Recent large double blind clinical trials have conftrmed the efficacy of various methods of secondary prevention. However, it seems that these tools are used insufficiently, and there may be opportunities for improvement. The aim of this study, which is a part of a larger inquiry about CHD patients, was to evaluate what kind of surveillance these patients receive by their FP and how secondary prevention is organized and implemented in general. Material and methods: All CHD patients with resi- dence in Hafnarfjörður, Garðabær and Bessastaða- hreppur (urban communities with 25,000 inhabi- tants), were invitated to participate in the study. They received an invitation letter and a request for an informed consent. If they chose to participate they answered a questionnaire about CHD risk factors and their medical treatment. Information about their CHD status was gathered by a review of their records at the respective health center. The patients were divided into four groups on the basis of their history: Frá 'Heilsugæslustöðinni Sólvangi, Hafnarfirði, 2heimilis- læknisfræði Háskóla íslands, 3Heilsugæslunni í Garðabæ, “lyflækningadeild Landspítalans. Fyrirspurnir, bréfaskipti: Emil L. Sigurðsson, Heilsugæslustöðinni Sólvangi, 220 Hafnarfirði. Sími: 550 2600, netfang: emilsig@solvangur. hgst.is Lykilorð: kransæðasjúkdómur, meðferð, forvarnir. I. Myocardial infarction (MI), II. coronary artery by- pass surgery (CABG), III. percutaneous transilumi- nal coronary angioplasty (PTCA), IV. angina pector- is (AP). If a patient fulfilled the critera for more than one diagnostic group the CABG group had the high- est priority followed by PTCA, MI and finally AP. Results: Of 533 patients with CHD 402 (75%) parti- cipated in the study. Electrocardiogram had been re- corded for 225 (56%) of these patients. Information about blood pressure was found for 369 (92%) and the mean systolic blood pressure was 143 mmHg (SD 19.8) and diastolic 82 mmHg (SD 9.5). Of CHD patients 15% were followed solely by their FP, 31% were exclusively followed by other specialists (car- diologists), 23% were followed both by FP and other specialists and 11% were without any medical sur- veillance. About 15% of the participants smoked, 12% were daily smokers and 56% were ex-smokers. Consultation report from a cardiologist had been sent to the respective FP for 43% of the patients. Conclusions: These results indicate that there is a number of opportunities to improve medical treat- ment and secondary prevention of CHD in Iceland. Improved organization of medical surveillance with clear definiton of treatment goals and ful! utilisation of those possibilities that are in the Icelandic health care system for secondary prevention, including im- provement in the exchange of informations between those involved in treating CHD. Keywords: coronary heart disease, treatment, prevention. Ágrip Tilgangur: Forvarnir, bæði fyrsta og annars stigs, eru mikilvægur þáttur í starfi flestra lækna. Heimilislæknar hafa mikilvægu hlut- verki að gegna í öllu forvarnarstarfi. Krans- æðasjúkdómur er dæmi um langvinnan sjúk- dóm þar sem meðal annars heimilislæknar koma að meðferð og eftirliti. Á síðustu árum hafa komið fram rannsóknarniðurstöður sem sýna hversu áhrifaríkar ýmsar aðgerðir í annars
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100

x

Læknablaðið

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið
https://timarit.is/publication/986

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.